Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Acquisitions (2021 - 2022)

Historic Acquisitions for Bioventus (BVS) over the last 2 years, with Q4 2022 value amounting to $104.6 million.

  • Bioventus' Acquisitions rose 32845.6% to $104.6 million in Q4 2022 from the same period last year, while for Oct 2022 it was $367.7 million, marking a year-over-year change of. This contributed to the annual value of $262.9 million for FY2021, which is N/A changed from last year.
  • As of Q4 2022, Bioventus' Acquisitions stood at $104.6 million, which was up 32845.6% from -$5000.0 recorded in Q3 2022.
  • In the past 5 years, Bioventus' Acquisitions registered a high of $262.9 million during Q4 2021, and its lowest value of -$45.8 million during Q4 2021.